These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32407484)

  • 1. CpG Methylation in TGFβ1 and IL-6 Genes as Surrogate Biomarkers for Diagnosis of IBD in Children.
    Samarani S; Dupont-Lucas C; Marcil V; Mack D; Israel D; Deslandres C; Jantchou P; Ahmad A; Amre D
    Inflamm Bowel Dis; 2020 Sep; 26(10):1572-1578. PubMed ID: 32407484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA methylation machinery and m
    Motawi TK; Shaker OG; Amr G; Senousy MA
    Clin Chim Acta; 2024 Jul; 561():119831. PubMed ID: 38925436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
    Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
    Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis.
    Burakoff R; Pabby V; Onyewadume L; Odze R; Adackapara C; Wang W; Friedman S; Hamilton M; Korzenik J; Levine J; Makrauer F; Cheng C; Smith HC; Liew CC; Chao S
    Inflamm Bowel Dis; 2015 May; 21(5):1132-40. PubMed ID: 25895006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
    Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
    J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
    Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
    PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis.
    Harris RA; Nagy-Szakal D; Mir SA; Frank E; Szigeti R; Kaplan JL; Bronsky J; Opekun A; Ferry GD; Winter H; Kellermayer R
    Epigenetics; 2014 Aug; 9(8):1131-7. PubMed ID: 24937444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
    Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
    Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
    Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
    Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci.
    Drobin K; Assadi G; Hong MG; Andersson E; Fredolini C; Forsström B; Reznichenko A; Akhter T; Ek WE; Bonfiglio F; Hansen MB; Sandberg K; Greco D; Repsilber D; Schwenk JM; D'Amato M; Halfvarson J
    Inflamm Bowel Dis; 2019 Jan; 25(2):306-316. PubMed ID: 30358838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood based discrimination of ulcerative colitis and Crohn's disease from non-IBD colitis by genome-wide gene expression profiling.
    Sipos F; Galamb O; Wichmann B; Krenács T; Tóth K; Leiszter K; Muzes G; Zágoni T; Tulassay Z; Molnár B
    Dis Markers; 2011; 30(1):1-17. PubMed ID: 21508504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease.
    Bjerrum JT; Nyberg C; Olsen J; Nielsen OH
    J Intern Med; 2014 May; 275(5):484-93. PubMed ID: 24206446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
    Vavricka SR; Spigaglia SM; Rogler G; Pittet V; Michetti P; Felley C; Mottet C; Braegger CP; Rogler D; Straumann A; Bauerfeind P; Fried M; Schoepfer AM;
    Inflamm Bowel Dis; 2012 Mar; 18(3):496-505. PubMed ID: 21509908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
    Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
    PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population.
    Halme L; Turunen U; Heliö T; Paavola P; Walle T; Miettinen A; Järvinen H; Kontula K; Färkkilä M
    Scand J Gastroenterol; 2002 Jun; 37(6):692-8. PubMed ID: 12126248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC.
    Venkateswaran S; Somineni HK; Matthews JD; Kilaru V; Hyams JS; Denson LA; Kellamayer R; Gibson G; Cutler DJ; Conneely KN; Smith AK; Kugathasan S
    Clin Epigenetics; 2023 Mar; 15(1):50. PubMed ID: 36964596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.